Paper396335
Opsonic specificity of human antibody to the type III polysaccharide of group B Streptococcus.
Edwards MS and 2 others. J Infect Dis, 1979. Cited by 93 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Opsonic specificity of human antibody to the type III polysaccharide of group B Streptococcus. Papers, record 396335. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/396335
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Opsonic specificity of human antibody to the type III polysaccharide of group B Streptococcus.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibody Specificity | Major topic |
| Opsonin Proteins | Major topic |
| Polysaccharides, Bacterial | Major topic |
| Streptococcus agalactiae | Major topic |
| Absorption | |
| Bacterial Vaccines | |
| Blood Bactericidal Activity | |
| Humans | |
| Neutrophils | |
| Oxygen Consumption | |
| Phagocytosis |
Source PubMed
Cited by35
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 93 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38,006,035 | Development of A Standardized Opsonophagocytosis Killing Assay for Group B Streptococcus and Assessment in an Interlaboratory Study. | Vaccines (Basel) | 2023 | https://conductscience.org/library/papers/38006035 | PubMed |
| 28,449,969 | Association between functional antibody against Group B Streptococcus and maternal and infant colonization in a Gambian cohort. | Vaccine | 2017 | https://conductscience.org/library/papers/28449969 | PubMed |
| 28,162,823 | Mucosal vaccination promotes clearance of Streptococcus agalactiae vaginal colonization. | Vaccine | 2017 | https://conductscience.org/library/papers/28162823 | PubMed |
| 27,803,803 | Group B Streptococcus vaccine development: present status and future considerations, with emphasis on perspectives for low and middle income countries. | F1000Res | 2016 | https://conductscience.org/library/papers/27803803 | PubMed |
| 26,608,922 | The Group B Streptococcus-Secreted Protein CIP Interacts with C4, Preventing C3b Deposition via the Lectin and Classical Complement Pathways. | J Immunol | 2016 | https://conductscience.org/library/papers/26608922 | PubMed |
| 25,589,553 | Antibody-mediated complement C3b/iC3b binding to group B Streptococcus in paired mother and baby serum samples in a refugee population on the Thailand-Myanmar border. | Clin Vaccine Immunol | 2015 | https://conductscience.org/library/papers/25589553 | PubMed |
| 24,554,752 | Characterization of invasive group B streptococcus strains from the greater Toronto area, Canada. | J Clin Microbiol | 2014 | https://conductscience.org/library/papers/24554752 | PubMed |
| 19,490,960 | Group B streptococcal conjugate vaccines elicit functional antibodies independent of strain O-acetylation. | Vaccine | 2009 | https://conductscience.org/library/papers/19490960 | PubMed |
| 18,155,812 | Alpha C protein-specific immunity in humans with group B streptococcal colonization and invasive disease. | Vaccine | 2008 | https://conductscience.org/library/papers/18155812 | PubMed |
| 17,938,215 | L-Ficolin/mannose-binding lectin-associated serine protease complexes bind to group B streptococci primarily through N-acetylneuraminic acid of capsular polysaccharide and activate the complement pathway. | Infect Immun | 2008 | https://conductscience.org/library/papers/17938215 | PubMed |
| 10,992,487 | Lectin site interaction with capsular polysaccharide mediates nonimmune phagocytosis of type III group B streptococci. | Infect Immun | 2000 | https://conductscience.org/library/papers/10992487 | PubMed |
| 10,722,601 | Nonopsonic binding of type III Group B Streptococci to human neutrophils induces interleukin-8 release mediated by the p38 mitogen-activated protein kinase pathway. | Infect Immun | 2000 | https://conductscience.org/library/papers/10722601 | PubMed |
| 9,826,364 | Estimation of group B streptococcus type III polysaccharide-specific antibody concentrations in human sera is antigen dependent. | Infect Immun | 1998 | https://conductscience.org/library/papers/9826364 | PubMed |
| 9,665,980 | Epidemiology of group B streptococcal disease in the United States: shifting paradigms. | Clin Microbiol Rev | 1998 | https://conductscience.org/library/papers/9665980 | PubMed |
| 9,536,123 | Group B streptococci persist inside macrophages. | Immunology | 1998 | https://conductscience.org/library/papers/9536123 | PubMed |
| 9,529,079 | Characterization of anticapsular monoclonal antibodies that regulate activation of the complement system by the Cryptococcus neoformans capsule. | Infect Immun | 1998 | https://conductscience.org/library/papers/9529079 | PubMed |
| 9,418,188 | Contribution of antibody to neutrophil-mediated killing of Enterococcus faecalis. | J Clin Immunol | 1997 | https://conductscience.org/library/papers/9418188 | PubMed |
| 8,698,468 | Entry and intracellular survival of group B streptococci in J774 macrophages. | Infect Immun | 1996 | https://conductscience.org/library/papers/8698468 | PubMed |
| 8,514,389 | Capsular polysaccharide regulates neutrophil complement receptor interactions with type III group B streptococci. | Infect Immun | 1993 | https://conductscience.org/library/papers/8514389 | PubMed |
| 8,454,344 | Neutrophil Fc receptor participation in phagocytosis of type III group B streptococci. | Infect Immun | 1993 | https://conductscience.org/library/papers/8454344 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/396335
GET https://conductscience.org/api/papers/v1/396335/cited_by?page=2